Peter Taylor

May 19, 2024 | nature.com | Emmanuel Aramendia |Paul Brockway |Peter Taylor |Jonathan Norman |Matthew Heun

AbstractThe net energy implications of the energy transition have so far been analysed at best at the final energy stage. Here we argue that expanding the analysis to the useful stage is crucial. We estimate fossil fuelsʼ useful-stage energy returns on investment (EROIs) over the period 1971–2020, globally and nationally, and disaggregate EROIs by end use.

May 11, 2024 | mdpi.com | Peter Taylor |P. A

This is an early access version, the complete PDF, HTML, and XML versions will be available soon. Open AccessArticlebyPeter A.

Oct 12, 2023 | nature.com | Peter Taylor

Since entering the clinic 25 years ago, biologic TNF inhibitors have transformed the outlook for people with rheumatoid arthritis and set the standard for all other targeted therapies. Despite changes to the therapeutic landscape, TNF inhibitors look set to remain an important treatment option for the foreseeable future. Contemporary trainees in rheumatology are certain to encounter people living with rheumatoid arthritis (RA) as it is the most common of the inflammatory polyarthritides.